pramipexole has been researched along with glutamic acid in 1 studies
Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (glutamic acid) | Trials (glutamic acid) | Recent Studies (post-2010) (glutamic acid) |
---|---|---|---|---|---|
1,103 | 219 | 517 | 41,757 | 452 | 12,876 |
Protein | Taxonomy | pramipexole (IC50) | glutamic acid (IC50) |
---|---|---|---|
Chain A, GLUTAMATE RECEPTOR SUBUNIT 2 | Rattus norvegicus (Norway rat) | 0.821 | |
Chain A, Glutamate Receptor Subunit 2 | Rattus norvegicus (Norway rat) | 0.821 | |
Chain B, Glutamate Receptor Subunit 2 | Rattus norvegicus (Norway rat) | 0.821 | |
Metabotropic glutamate receptor 8 | Homo sapiens (human) | 0.0057 | |
Glutamate receptor ionotropic, NMDA 2D | Homo sapiens (human) | 0.07 | |
Glutamate receptor ionotropic, NMDA 3B | Homo sapiens (human) | 0.07 | |
Glutamate receptor 1 | Rattus norvegicus (Norway rat) | 0.5885 | |
Glutamate receptor 2 | Rattus norvegicus (Norway rat) | 0.5885 | |
Glutamate receptor 3 | Rattus norvegicus (Norway rat) | 0.5885 | |
Glutamate receptor 4 | Rattus norvegicus (Norway rat) | 0.5885 | |
Glutamate receptor ionotropic, kainate 1 | Rattus norvegicus (Norway rat) | 0.38 | |
Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.1533 | |
Glutamate receptor ionotropic, kainate 2 | Rattus norvegicus (Norway rat) | 0.38 | |
Glutamate receptor 1 | Homo sapiens (human) | 0.613 | |
Glutamate receptor 2 | Homo sapiens (human) | 0.613 | |
Glutamate receptor 3 | Homo sapiens (human) | 0.613 | |
Glutamate receptor ionotropic, kainate 3 | Rattus norvegicus (Norway rat) | 0.38 | |
Excitatory amino acid transporter 1 | Homo sapiens (human) | 207 | |
Glutamate receptor 4 | Homo sapiens (human) | 0.613 | |
Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.1533 | |
Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.1533 | |
Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.1533 | |
Glutamate receptor ionotropic, kainate 4 | Rattus norvegicus (Norway rat) | 0.38 | |
Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | 0.07 | |
Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | 0.07 | |
Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | 0.07 | |
Glutamate receptor ionotropic, NMDA 2C | Homo sapiens (human) | 0.07 | |
Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.1533 | |
Glutamate receptor ionotropic, kainate 5 | Rattus norvegicus (Norway rat) | 0.38 | |
Glutamate receptor ionotropic, NMDA 3A | Homo sapiens (human) | 0.07 | |
Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.1533 | |
Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.1533 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akaike, A; Izumi, Y; Katsuki, H; Kume, T; Sawada, H; Shimohama, S; Yamamoto, N | 1 |
1 other study(ies) available for pramipexole and glutamic acid
Article | Year |
---|---|
Novel neuroprotective mechanisms of pramipexole, an anti-Parkinson drug, against endogenous dopamine-mediated excitotoxicity.
Topics: Animals; Antiparkinson Agents; Benzothiazoles; Cell Survival; Cells, Cultured; Dopamine; Dose-Response Relationship, Drug; Glutamic Acid; Immunohistochemistry; Mesencephalon; Neurons; Neuroprotective Agents; Parkinson Disease; Pramipexole; Rats | 2007 |